Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

November 10, 2021
BioUtah News
Renalytix Convenes Expert Panel at VA Healthcare Summit

Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease

November 9, 2021
BioUtah News
St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York

Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease

November 4, 2021
COVID-19 Updates Policy News
U.S. Department of Labor’s Occupational Safety and Health Administration Unveils Rule to Mandate COVID-19 Vaccines for Large Employers

The Department of Labor’s Occupational Safety and Health Administration (OSHA) yesterday issued a rule requiring employers with 100 or more employees to enforce a mandatory COVID-19 vaccination policy, unless they adopt a policy requiring employees to choose to either be vaccinated or undergo regular COVID-19 testing and wear a face covering at work. The rule, […]

November 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma 

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in a Phase 1 study evaluating its investigational agent DSP-0390, an emopamil-binding protein (EBP) inhibitor, for the treatment of patients with recurrent high-grade glioma. “Dosing the first patient in this study represents another […]

November 4, 2021
BioUtah News
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom

Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations

November 3, 2021
BioUtah News
New report shows more than 260 medicines in development to fight neurodegenerative diseases

PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases

November 3, 2021
BioUtah News
Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial

Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).

November 3, 2021
BioUtah News
Wilson Sonsini to open Salt Lake City office with trio of lawyers

Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S. law firm to plant a flag in the tech-heavy region sometimes called “Silicon Slopes.”

November 3, 2021
BioUtah News
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans

Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on recent business performance and strategic transformation plans.  

November 3, 2021
BioUtah News
FDA Clears 12 New XO Cross Microcatheters

12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.

November 3, 2021
BioUtah News
St. George could become Utah’s next tech hub

Utah has now become a VC darling with a maturing ecosystem complete with angels, seed-stage, growth stage, and private equity investors, says Brad Plothow, VP of strategy at St. George aerospace startup Intergalactic.

November 3, 2021
BioUtah News
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery

Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery